Using molecular structures to choose the best therapy. Currently focusing on mutations in EGFR and other lung cancer drivers. Working closely with the Molecular Tumor Board at the UMCG #umcg and patient organizations across Europe.
| Website | https://www.protyon.tech |
| Employees | 8 (7 on RocketReach) |
| Founded | 2022 |
| Industry | Hospitals and Health Care |
| Keywords | Cancer Therapy, Precision Medicine, Personalized Medicine, Targeted Therapy, Lung Cancer Research, Molecular Diagnostics, Mutation Analysis, Oncology, Genomic Analysis, Therapeutic Development, Drug Discovery, Cancer Biomarkers, Pharmaceutical Research, Biotechnology, Medical Research, Clinical Trials, Patient Advocacy |
| Competitors | Microsoft, Creaform, Vicon, TWI, Xsens, Motion Analysis Corporation, Simi Reality Motion Systems, OptiTrack, BioDigital, Qualisys +27 more (view full list) |
Looking for a particular Protyon employee's phone or email?
Rositsa Jordanova is the CEO of Protyon.
7 people are employed at Protyon.
Protyon is based in Groningen, Groningen.